findmyKOL
Clinical trialNCT02276560TerminatedPhase 2Interventional

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

SponsorUNC Lineberger Comprehensive Cancer CenterEnrollment1Stage IIIA Non-Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

  • Emory - Winship Cancer Institute

    Atlanta, Georgia, United States

  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

  • Ochsner Cancer Institute

    New Orleans, Louisiana, United States

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina, United States

  • Rex Cancer Center and Rex of Wakefield

    Raleigh, North Carolina, United States

  • Case Western Reserve University - Seidman Cancer Center

    Cleveland, Ohio, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

  • Swedish Cancer Institute

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2015
Primary completion
30 Jun 2016
Completion
30 Jun 2016
Last update posted
11 May 2017
Registered enrollment
1
Registry id
NCT02276560

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.